← Leaderboards
Peter M. Eimon
Zygogen, Llc
$1,665,411
Attributed
$1,665,411
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $818.6K · FY2006–08$1M$750K$500K$250K$0
'06
'07
'08
Funding mix
By agency
NIH$1,665,411 · 4
By mechanism
R44$1,350,282 · 2
R43$315,129 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseZebrafishClinical TrialsIn VivoReporterTransgenic OrganismsPre-ClinicalAngiogenesis InhibitorsAngiogenesisAffectAstemizoleBlindnessBlood VesselsCalcium Channel BlockersAssay DevelopmentArrhythmiaAnalogCardiotoxicityCardiac GlycosidesClinical Trials, Phase IClinical Trials, Phase IiCollaborationsCoralArea
Grant awards (4)
Compound Screening in Z-Tag Zebrafish Angiogenesis Assay$692,782
R44 · FY2008 · CA · contact PI
Z-Tag for Measuring Cardiac Contractility and Cardiac Rhythmicity$153,994
R43 · FY2007 · HL · contact PI
Zebrafish Lipid Metabolism Assay for Drug Screening$657,500
R44 · FY2006 · DK · contact PI
Zebrafish Assay for Parkinson's Disease Drugs$161,135
R43 · FY2006 · NS · contact PI